Identification of tissue factor and platelet-derived particles on leukocytes during cardiopulmonary bypass by flow cytometry and immunoelectron microscopy

Summary

The extrinsic coagulation system initiated by tissue factor (TF) appears to be a major procoagulant stimulus during cardiopulmonary bypass (CPB), although the precise mechanisms remain to be revealed.We recently reported the appearance ofTF-bearing leukocytes during CPB and described their role in promoting coagulation. In this study, we visually identified the in-vivo appearance ofTF-bearing leukocytes and platelet-derived particles on leukocytes in the pericardial blood during cardiac surgery with CPB, by flow cytometry and immunoelectron microscopy. Preliminary flow cytometric experiments showed that the proportion of TF-positive or both TF- and platelet antigen CD41a-positive leukocytes was increased markedly in pericardial blood obtained during CPB,compared with the proportions in preoperative circulating blood. Immunoelectron microscopic analysis revealed that both monocytes and polymorphonuclear leukocytes in the pericardial blood express TF. On the surfaces of these cells, CD41a-positive or both CD41a- and TF-positive platelet-derived particles were observed. Platelet-derived particles include not only microparticles, but also platelets themselves. Leukocytes from preoperative circulating blood contained far fewer of these particles. Our results demonstrate the in-vivo appearance of TF-bearing platelet-derived particles on leukocytes during cardiac surgery with CPB.These findings may be important for the development of strategies to control procoagulant activities during and after cardiac surgery.

Keywords

Tissue factor (TF) - cardiopulmonary bypass (CPB) - monocytes - polymorphonuclear leukocytes (PMNs) - platelet-derived microparticles (MPs) - flow cytometry - immunoelectron microscopy

• References

• 1 Philippou H, Adami A, Davidson SJ. et al. Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass. Thromb Haemost 2000; 84: 124-128.
• 2 Tabuchi N, de Haan J, Boonstra PW. et al. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 106: 828-833.
• 3 Shibamiya A, Tabuchi N, Chung J. et al. Formation of tissue factor-bearing leukocytes during and after cardiopulmonary bypass. Thromb Haemost 2004; 92: 124-131.
• 4 Ernofsson M, Thelin S, Siegbahn A. Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study. J Thorac Cardiovasc Surg 1997; 113: 576-584.
• 5 Maugeri N, Brambilla M, Camera M. et al. Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. J Thromb Haemost 2006; 4: 1323-1330.
• 6 Lindmark E, Tenno T, Siegbahn A. Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arterioscler Thromb Vasc Biol 2000; 20: 2322-2328.
• 7 Scholz T, Temmler U, Krause S. et al. Transfer of tissue factor from platelets to monocytes: role of platelet- derived microvesicles and CD62P. Thromb Haemost 2002; 88: 1033-1038.
• 8 Zillmann A, Luther T, Müller I. et al. Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation. Biochem Biophys Res Commun 2001; 281: 603-609.
• 9 Müller I, Klocke A, Alex M. et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J 2003; 17: 476-478.
• 10 Mackman N. Alternatively spliced tissue factor – one cut too many?. Thromb Haemost 2007; 97: 5-8.
• 11 Censarek P, Bobbe A, Grandoch M. et al. Alternatively spliced human tissue factor (asHTF) is not procoagulant. Thromb Haemost 2007; 97: 11-14.
• 12 Suzuki H, Yokomizo S, Wakamoto S. et al. Translocation of sLex on the azurophilic granule membrane to the plasma membrane in activated human neutrophils. J Electron Microsc 2000; 49: 359-370.
• 13 Suzuki H, Nakamura S, Itoh Y. et al. Immunocytochemical evidence for the translocation of α-granule membrane glycoprotein IIb/IIIa (integrin αIIbβ3) of human platelets to the surface membrane during the release reaction. Histochemistry 1992; 97: 381-388.
• 14 Camera M, Frigerio M, Toschi V. et al. Platelet activation induces cell-surface immunoreactive tissue factor expression, which is modulated differently by antiplatelet drugs. Arterioscler Thromb Vasc Biol 2003; 23: 1690-1696.
• 15 Hron G, Kollars M, Weber H. et al. Tissue factorpositive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost 2007; 97: 119-123.
• 16 Tan KT, Lip GY. The potential role of platelet microparticles in atherosclerosis. Thromb Haemost 2005; 94: 488-492.
• 17 Tabuchi N, Shibamiya A, Koyama T. et al. Activated leukocytes adsorbed on the surface of an extracorporeal circuit. Artif Organs 2003; 27: 591-594.
• 18 Morgan EN, Pohlman TH, Vocelka C. et al. Nuclear factor κB mediates a procoagulant response in monocytes during extracorporeal circulation. J Thorac Cardiovasc Surg 2003; 125: 165-171.
• 19 Ohsawa M, Koyama T, Yamamoto K. et al. 1α,25-dihydroxyvitamin D3 and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL. Circulation 2000; 102: 2867-2872.
• 20 Lindmark E, Wallentin L, Siegbahn A. Blood cell activation, coagulation, and inflammation in men and women with coronary artery disease. Thromb Res 2001; 103: 249-259.
• 21 Arefieva TI, Provatorov SI, Samko AN. et al. Monocyte integrin expression and monocyte-platelet complex formation in humans with coronary restenosis. Clin Exp Pharmacol Physiol 2001; 28: 804-808.
• 22 Khan MM, Hattori T, Niewiarowski S. et al. Truncated and microparticle-free soluble tissue factor bound to peripheral monocytes preferentially activate factor VII. Thromb Haemost 2006; 95: 462-468.
• 23 Siddiqui FA, Desai H, Amirkhosravi A. et al. The presence and release of tissue factor from human platelets. Platelets 2002; 13: 247-253.
• 24 Mechiche H, Cornillet-Lefebvre P, Nguyen P. A subpopulation of human B lymphocytes can express a functional Tissue Factor in response to phorbol myristate acetate. Thromb Haemost 2005; 94: 146-154.
• 25 De Waard V, Hansen HR, Spronk HH. et al. Differential expression of tissue factor mRNA and protein expression in murine sepsis. The role of the granulocyte revisited. Thromb Haemost 2006; 95: 348-353.
• 26 Falanga A, Marchetti M, Vignoli A. et al. Leukocyte- platelet interaction in patients with essential thrombocythemia and polycythemia vera. Exp Hematol 2005; 33: 523-530.
• 27 Maugeri N, Giordano G, Petrilli MP. et al. Inhibition of tissue factor expression by hydroxyurea in polymorphonuclear leukocytes from patients with myeloproliferative disorders: a new effect for an old drug?. J Thromb Haemost 2006; 4: 2593-2598.
• 28 Nakamura S, Imamura T, Okamoto K. Tissue factor in neutrophils: yes. J Thromb Haemost 2004; 2: 214-217.
• 29 Østerud B. Tissue factor in neutrophils: no. J Thromb Haemost 2004; 2: 218-220.
• 30 Lopez-Vilchez I, Escolar G, Diaz-Ricart M. et al. Tissue factor-enriched vesicles are taken up by platelets and induce platelet aggregation in the presence of factor VIIa. Thromb Haemost 2007; 97: 202-211.